Wednesday, June 10, 2026

Drug profile · INN

alum

alum (NULL) is an FDA-listed pharmaceutical active ingredient.

TGA: approved
Patents linked 1
Pipeline programs 7
News articles 1
Drug details — alum

Quick answer

alum (NULL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN alum
Brand NULL

Approval history

Authority Status Date
TGA approved

Recent coverage

Pipeline programs

  1. Metformina Uxa comprimidos recubiertos con pe... Phase 3 · George Institute for · Chronic Obstructive Pulmonary Disease (COPD)
  2. NI-501; emapalumab, NI-501; emapalumab Phase 3 · SWEDISH ORPHAN BIOVITRUM · Macrophage activation syndrome (MAS) in the context of Syste
  3. ianalumab s.c. q4w Phase 3 · Novartis India · Lupus Nephritis
  4. Extraluminal use of Univent bronchial Blocker Phase 1 · Hospital Authority · Therapeutic Procedural Complication
  5. NDV-3 vaccine with alum IM Phase 1 · United Therapeutics Europe · Staphylococcal Infections
  6. Tabalumab Phase 1 · Eli Lilly and · Multiple Myeloma
  7. LP0160-1329 Approved · LEO Pharma US · Moderate-to-severe plaque psoriasis and a body weight ≥120 k

Related patents

  1. US 9650256

    Cerium oxide-aluminosilicate tubes nanocomposite and method of preparation

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is alum?

alum (NULL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for alum?

NULL is a marketed brand name for alum. Check FDA Drugs@FDA for the current US label holder and prescribing information.